ErinRenee(Olson)MacraeMD

Oncology • Columbus, OH

Physician

Join to view full profile

Dr. Macrae is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Macrae's full profile

Already have an account?

Office
810 Jasonway Ave
Ste A
Columbus, OH 43214
Phone+1 614-442-3130

Fax+1 614-442-3145
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2011
University of Pennsylvania Health SystemResidency, Internal Medicine, 2005 - 2008
Case Western Reserve University School of MedicineClass of 2005

Certifications & Licensure

OH State Medical License 2011 - 2026
PA State Medical License 2005 - 2008
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Start of enrollment: 2013 May 01
Active, not recruiting
Phase 2
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer Start of enrollment: 2013 Oct 02
Completed
Phase 2
Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H) Start of enrollment: 2015 Aug 12
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

88 citations
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update.
Harold J. Burstein, Mark R. Somerfield, Debra L. Barton, Ali Dorris, Lesley Fallowfield, Dharamvir Jain, Stephen R. D. Johnston, Larissa A. Korde, Jennifer K. Litton, ...> ;Journal of Clinical Oncology. 2021 Jul 29
3 citations
Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells
Heather A. Parsons, Erin R. Macrae, Hao Guo, Tianyu Li, William T. Barry, Nabihah Tayob, Gerburg M. Wulf, Steven J. Isakoff, Ian E. Krop> ;JCO Precision Oncology. 2021 May 20
118 citations
Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Results of the NCI-MATCH Trial Subprotocol H.
April K.S. Salama, Shuli Li, Erin Macrae, Jong-In Park, Edith P. Mitchell, James A. Zwiebel, Helen X. Chen, Robert Gray, Lisa M. McShane, Larry Rubinstein, David Patto...> ;Journal of Clinical Oncology. 2020 Aug 6
8 citations
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine P...
Robert Wesolowski, Daniel G. Stover, Maryam B. Lustberg, Abigail B. Shoben, Meng Zhao, Ewa Mrozek, Rachel M. Layman, Erin Macrae, Wenrui Duan, Jun Zhang, Nathan Hall, ...> ;The Oncologist. 2020 Aug 1
12 citations
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable b...
Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, Christopher McQuinn, Zaibo Li, Hiroaki Nitta, Himanshu Savardekar, Brooke Benner, Bhuvaneswari Ramaswamy, Maryam B. ...> ;BMC Cancer. 2020 May 19
8 citations
Metastatic breast cancer patient perceptions of somatic tumor genomic testing
Elizabeth J. Adams, Sarah Asad, Raquel E. Reinbolt, Katharine Collier, Mahmoud Abdel-Rasoul, Susan Gillespie, James L. Chen, Mathew Cherian, Anne M. Noonan, Sagar Sard...> ;BMC Cancer. 2020 May 6
9 citations
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions.
Daniel G. Stover, Raquel E. Reinbolt, Elizabeth J. Adams, Sarah Asad, Katlyn Tolliver, Mahmoud Abdel-Rasoul, Cynthia Timmers, Susan Gillespie, James L. Chen, Siraj M. ...> ;JCO Precision Oncology. 2019 Nov 18
50 citations
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer
Robert Wesolowski, Megan C. Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Kala M. Levine, Lynn Schoenfield, Mahmoud Abdel-Rasoul, Rachel M. Layman, Bhuvanes...> ;Cancer Immunology, Immunotherapy. 2017 Jul 7
378 citations
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
Hope S. Rugo, R. Bryan Rumble, Erin Macrae, Debra L. Barton, Hannah Klein Connolly, Maura N. Dickler, Lesley Fallowfield, Barbara Fowble, James N. Ingle, Mohammad Jaha...> ;Journal of Clinical Oncology. 2016 Sep 27
23 citations
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo
Enrico Caserta, Onur Egriboz, Hui Wang, Chelsea K. Martin, Christopher Koivisto, Thierry Pécot, Raleigh D. Kladney, Changxian Shen, Kang Sup Shim, Thac Pham, Matthew K...> ;Genes & Development. 2015 Aug 15
19 citations
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
Michael Berger, Craig A. Vargo, Mary Vincent, Katy Shaver, Gary Phillips, Rachel M. Layman, Erin Macrae, Ewa Mrozek, Bhuvaneswari Ramaswamy, Robert Wesolowski, Charles...> ;Supportive Care in Cancer. 2015 Jul 1
38 citations
Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a...
Mellissa Hicks, Erin Macrae, Mahmoud Abdel-Rasoul, Rachel M. Layman, Susan Friedman, Jenny Querry, Maryam B. Lustberg, Bhuvaneswari Ramaswamy, Ewa Mrozek, Charles L. S...> ;The Oncologist. 2015 Apr 1
7 citations
Mitogen-activated protein kinase signaling controls basal and oncostatin M-mediated JUNB gene expression.
Mellissa Hicks, Qiuping Hu, Erin Macrae, James W. DeWille> ;Molecular and Cellular Biochemistry. 2015 Feb 8
29 citations
Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer.
Drew R Oostra, Erin Macrae> ;Breast Cancer. 2014 Jul 23
9 citations
JUNB promotes the survival of Flavopiridol treated human breast cancer cells
Mellissa Hicks, Qiuping Hu, Erin Macrae, James W. DeWille> ;Biochemical and Biophysical Research Communications. 2014 Jul 18
11 citations
A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer
Meng Zhao, Xueliang Pan, Rachel M. Layman, Maryam B. Lustberg, Ewa Mrozek, Erin Macrae, Robert Wesolowski, Sarah Carothers, Shannon Puhalla, Charles L. Shapiro, Bhuvan...> ;Investigational New Drugs. 2014 Jun 5
10 citations
Treatment-Related Mortality With Everolimus in Cancer Patients
Robert Wesolowski, Mahmoud Abdel-Rasoul, Maryam B. Lustberg, Maria Paskell, Charles L. Shapiro, Erin Macrae> ;The Oncologist. 2014 Jun 1
13 citations
Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival
Joseph J. Maly, Erin Macrae> ;Breast Cancer. 2014 May 12
75 citations
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
Maryam B. Lustberg, Priya Balasubramanian, Brandon Miller, Alejandra Garcia-Villa, Clayton Deighan, Yongqi Wu, Sarah Carothers, Michael Berger, Bhuvaneswari Ramaswamy,...> ;Breast Cancer Research. 2014 Mar 6
32 citations
Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy
Davinia S.E. Seah, Ines Maria Vaz Duarte Luis, Erin Macrae, Jessica Sohl, Georgia Litsas, Eric P. Winer, Nan Lin, Harold J. Burstein> ;Journal of the National Comprehensive Cancer Network. 2014 Jan 1
93 citations
Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era
Erin M. Olson, Julie Najita, Jessica Sohl, Amal Arnaout, Harold J. Burstein, Eric P. Winer, Nan Lin> ;Breast. 2013 Aug 1
When Standard Therapy Fails in Breast Cancer: Current and Future Options for HER2-Positive Disease.
Olson, E.,Mullins, D.> ;J Clin Trials. 2014 Feb 15
Author's reply: Use of discard pleural fluid in molecular research.
Erin M. Olson, Nan Lin, Ian E. Krop, Eric P. Winer> ;Nature Reviews. Clinical Oncology. 2012 Jan 1
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management.
Mato, A.R., Morgans, A.K., Roullet, M.R., Bagg, A., Glatstein, E., Litt, H.I., Downs, L.H., Chong, E.A., Olson, E.R., Andreadis, C., Schuster, S.J.> ;Cancer Biol Ther. 2007 Dec
Join now to see all

Press Mentions

Examples Help Breast Cancer Patients UnderstandMarch 31st, 2017

Hospital Affiliations

The OSUCCC - JamesColumbus, Ohio
OhioHealth Riverside Methodist HospitalColumbus, Ohio